It is a personalized nutritional strategy designed to support the specific biological processes that BPC-157 is activating in your body
Written by: FormBlends Medical Team
Veljaca, Marija et al, The development of PL 14736 for treatment of inflammatory bowel disease, Advanced in GI pharmacology, 2002 O-32
According to studies, there are no side effects or toxic effects from using BPC 157 (Chang CH, 2011)
If you think you may have a medical emergency, seek in person emergency care immediately, call your doctor or 000 immediately
Published pharmacokinetic data from the Theratechnologies clinical program show a plasma half-life of approximately 26 to 38 minutes after subcutaneous injection in HIV-infected adult patients, depending on dose and study cohort